| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1025389 |
| landingPage: |
http://www.iedb.org/assay/1966635 |
| type: |
Literature
|
| publicationVenue: |
J Neuroimmunol
|
| dates: |
2013
|
| study type: | b cell assays |
| subject species: | Homo sapiens |
| fullName: |
Doris Lambracht-Washington
Bao-xi Qu
Min Fu
Larry D Anderson Jr
Todd N Eagar
Olaf Stü
ve
Roger N Rosenberg
|
| method: |
ELISA
|
| name: |
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Abeta42 DNA vaccine for Alzheimer disease.
|
| description: |
The epitope sequence was provided in cited reference Qu et al. Arch Neurol 2004
61:1859 [PMID:15596606].
Epitope-specific plasma IgG2a/c was detected in mice primed with the AB1-42 peptide encoded in pDNA and then boosted with the epitope alone. Reactivity was low or non-existent following immunization with AB1-42 alone given with QuilA or with AB1-42 encoded plasmid alone or AB1-42 peptide prime, pDNA boost.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |